Weight loss medications have become one of the most talked-about developments in modern healthcare, particularly for people struggling to lose weight through diet and exercise alone. Two names that continue to dominate the conversation are Mounjaro and Wegovy.
Both treatments are prescription-only injections designed to support long-term weight management, but they work slightly differently and may suit different people depending on their health goals, medical history, and lifestyle.
In this guide, we’ll compare Mounjaro and Wegovy in detail, including how they work, expected results, side effects, costs, and which treatment may be more effective for weight loss.
Mounjaro contains the active ingredient tirzepatide. It was originally developed to help manage type 2 diabetes, but it has quickly become recognised as one of the most effective weight loss injections currently available.
Mounjaro works by mimicking two naturally occurring hormones in the body:
These hormones help regulate appetite, slow digestion, and improve blood sugar control. As a result, many people feel fuller for longer and naturally consume fewer calories.
Mounjaro is taken once weekly using a pre-filled injection pen.
Wegovy contains semaglutide, a medication designed specifically for weight management.
Like Mounjaro, Wegovy is a once-weekly injection that helps reduce appetite and cravings. However, Wegovy targets only one hormone pathway, GLP-1.
This helps users:
Wegovy has become particularly popular in the UK due to strong clinical trial results and growing NHS awareness around obesity treatment.
The biggest difference between Mounjaro and Wegovy is how they work inside the body.
Mounjaro activates both GLP-1 and GIP receptors, while Wegovy works only on GLP-1 receptors.
This dual-action approach is believed to be one reason why Mounjaro has shown greater average weight loss results in clinical studies.
| Feature | Mounjaro | Wegovy |
| Active ingredient | Tirzepatide | Semaglutide |
| Injection frequency | Once weekly | Once weekly |
| Hormones targeted | GLP-1 + GIP | GLP-1 only |
| Appetite suppression | Strong | Strong |
| Average weight loss | Higher in studies | Very effective |
| Prescription required | Yes | Yes |
| Suitable for long-term use | Yes | Yes |
Both medications can produce significant weight loss when combined with a calorie-controlled diet and increased physical activity. However, current evidence suggests that Mounjaro may lead to greater overall weight reduction for many patients.
Some clinical trials have shown participants using tirzepatide achieving weight loss exceeding 20% of their body weight over time.
Wegovy has also delivered impressive results, with many users losing around 10% to 15% of their starting weight during longer-term treatment programmes.
It is important to remember that results vary from person to person. Factors such as lifestyle, dosage progression, consistency, and existing health conditions all play a role.
Neither medication is designed as a quick fix.
Most patients begin on a low dose to minimise side effects before gradually increasing over several weeks or months.
Many people notice:
Healthy, sustainable weight loss is usually more successful long term than rapid short-term dieting.
Like all prescription medications, both Mounjaro and Wegovy can cause side effects.
The most common include:
These symptoms are often temporary and may improve as the body adjusts to treatment.
Eating smaller meals, staying hydrated, and avoiding greasy or overly rich foods can sometimes help reduce digestive side effects.
Anyone experiencing severe or persistent symptoms should seek advice from a qualified healthcare professional.
Weight loss injections are generally prescribed for adults who meet certain BMI criteria, particularly if weight-related health concerns are present.
You may be considered suitable if you:
Treatment suitability should always be assessed by a qualified prescriber following a medical consultation.
These medications are not suitable for everyone, particularly individuals with certain gastrointestinal conditions, a history of pancreatitis, or some thyroid-related conditions.
Pricing can vary depending on:
In many cases, lower starting doses are cheaper, while maintenance doses cost more as treatment progresses.
Although Mounjaro is often slightly more expensive, some patients feel the increased effectiveness justifies the higher cost.
When comparing prices, it is important to consider:
Choosing a regulated UK pharmacy is essential when purchasing prescription weight loss medication online.
While both treatments can support substantial weight loss, neither medication replaces healthy habits.
The best results usually come from combining treatment with:
Patients who build sustainable routines alongside medication often achieve better long-term outcomes.
There is no universal answer.
For some patients, Mounjaro may provide stronger appetite suppression and greater weight loss results. For others, Wegovy may be more suitable due to availability, tolerance, pricing, or previous medical history.
The right treatment depends on the individual.
A qualified healthcare professional can help determine which option may align best with your needs and weight loss goals.
Both Mounjaro and Wegovy represent a major shift in modern weight management treatment.
They are helping many people achieve meaningful, sustainable weight loss when traditional approaches alone have not worked.
Mounjaro currently appears to offer the strongest weight loss potential based on available clinical data, while Wegovy remains one of the most trusted and widely used options in the UK.
Whichever treatment is chosen, medical supervision, realistic expectations, and long-term lifestyle changes remain essential for lasting success.
Yes, some patients move from Wegovy to Mounjaro under medical supervision, particularly if weight loss has slowed or side effects become problematic.
Both medications share similar digestive side effects. Some people tolerate one better than the other, but experiences vary between individuals.
Weight regain can happen if healthy eating habits and lifestyle changes are not maintained after treatment ends.
Yes, both treatments are available through regulated UK prescribing services and pharmacies following eligibility assessments.
Some patients report faster appetite suppression with Mounjaro, though individual results vary significantly.